ArticleNMC case report journal2026
Oral Contraceptive Use and Acute Ischemic Stroke Risk in Patients with Moyamoya Disease.
Article in NMC case report journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate whether oral contraceptives induce acute ischemic stroke in patients with moyamoya disease. We retrospectively reviewed female patients with moyamoya disease who were taking oral contraceptives during their reproductive years (12-49 years of age) at the time of diagnosis or during follow-up. The patients' detailed clinical history, including the time course of oral contraceptive usage and acute ischemic stroke occurrence, was evaluated. For patients with radiological evidence of acute ischemic stroke, the imaging pattern of stroke was assessed to investigate the underlying mechanisms. Among 589 female patients, 12 patients took oral contraceptives at some point during the period from 2012 to 2023; 5 patients were taking oral contraceptives at the time of diagnosis, and 4 of them were diagnosed with moyamoya disease after acute ischemic stroke. Among the 7 patients who started oral contraceptives during follow-up, 2 patients developed acute ischemic stroke several months after starting oral contraceptives. Notably, none of the hemispheres that developed acute ischemic stroke previously underwent revascularization, and none of the 5 hemispheres with prior revascularization developed acute ischemic stroke. The imaging pattern of acute ischemic stroke in 7 patients suggested the contribution of a thromboembolic mechanism. Oral contraceptives may increase the risk of acute ischemic stroke via thromboembolic mechanisms in patients with moyamoya disease, but its risk might be manageable in hemispheres with prior revascularization and stable disease conditions for years. Active education of patients regarding the possible risk of oral contraceptives and close communication with gynecologists seem necessary to provide the best treatment strategies for female patients with moyamoya disease who require contraception or treatment of menstrual disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.